rolipram has been researched along with Kidney Diseases in 4 studies
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effect of Rolipram, a phosphodiesterase-4-inhibitor, on renal ischemia-reperfusion injury (IRI) in rats." | 7.78 | Protective effects of phosphodiesterase-4-specific inhibitor rolipram on acute ischemia-reperfusion injury in rat kidney. ( Abat, D; Acikalin, A; Aridogan, IA; Bayazit, Y; Izol, V; Mammadov, E; Tuli, A, 2012) |
| "To investigate the effect of Rolipram, a phosphodiesterase-4-inhibitor, on renal ischemia-reperfusion injury (IRI) in rats." | 3.78 | Protective effects of phosphodiesterase-4-specific inhibitor rolipram on acute ischemia-reperfusion injury in rat kidney. ( Abat, D; Acikalin, A; Aridogan, IA; Bayazit, Y; Izol, V; Mammadov, E; Tuli, A, 2012) |
| "Renal interstitial inflammation is a consequence of unilateral ureteral obstruction (UUO)." | 1.33 | A2A adenosine receptor agonist and PDE4 inhibition delays inflammation but fails to reduce injury in experimental obstructive nephropathy. ( Chevalier, RL; Forbes, MS; Lange-Sperandio, B; Linden, J; Okusa, MD; Thornhill, B, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, WC | 1 |
| Beltrami, VA | 1 |
| Campolina-Silva, GH | 1 |
| Queiroz-Junior, CM | 1 |
| Florentino, RM | 1 |
| Machado, JR | 1 |
| Martins, DG | 1 |
| Gonçalves, WA | 1 |
| Barroso, LC | 1 |
| Freitas, KM | 1 |
| de Souza-Neto, FP | 1 |
| Félix, FB | 1 |
| da Silva, RF | 1 |
| Oliveira, CA | 1 |
| Câmara, NOS | 1 |
| Rachid, MA | 1 |
| Teixeira, MM | 1 |
| Rezende, BM | 1 |
| Pinho, V | 1 |
| Mammadov, E | 1 |
| Aridogan, IA | 1 |
| Izol, V | 1 |
| Acikalin, A | 1 |
| Abat, D | 1 |
| Tuli, A | 1 |
| Bayazit, Y | 1 |
| Lange-Sperandio, B | 1 |
| Forbes, MS | 1 |
| Thornhill, B | 1 |
| Okusa, MD | 1 |
| Linden, J | 1 |
| Chevalier, RL | 1 |
| Coffey, AK | 1 |
| O'Sullivan, DJ | 1 |
| Homma, S | 1 |
| Dousa, TP | 1 |
| Valtin, H | 1 |
4 other studies available for rolipram and Kidney Diseases
| Article | Year |
|---|---|
Therapeutic treatment with phosphodiesterase-4 inhibitors alleviates kidney injury and renal fibrosis by increasing MMP-9 in a doxorubicin-induced nephrotoxicity mouse model.
Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Fibrosis; Hypercholes | 2023 |
Protective effects of phosphodiesterase-4-specific inhibitor rolipram on acute ischemia-reperfusion injury in rat kidney.
Topics: Animals; Catalase; Kidney Diseases; Lipid Peroxidation; Malondialdehyde; Phosphodiesterase 4 Inhibit | 2012 |
A2A adenosine receptor agonist and PDE4 inhibition delays inflammation but fails to reduce injury in experimental obstructive nephropathy.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Apoptosis; Cell Proliferation; Cyclic Nucleotide Phosp | 2005 |
Induction of intramembranous particle clusters in mice with nephrogenic diabetes insipidus.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cell Membrane; Cyclic AMP; Diabetes Insipidus; Freeze | 1991 |